Pathogenic and immunogenic responses in turkeys following in ovo exposure to avian metapneumovirus subtype C

Ra Mi Cha1, Mahesh Khatri, Manohar Mutnal

  • 1Department of Veterinary and Biomedical Sciences, University of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, USA.

Insights

In ovo inoculation of avian metapneumovirus subtype C (aMPV/C) into turkey eggs did not affect hatchability but induced immune responses and protection against later challenge. This study highlights the potential of in ovo immunization for controlling aMPV/C in turkeys.

Area of Science:

  • Veterinary Virology
  • Immunology
  • Poultry Science

Background:

  • Avian metapneumovirus subtype C (aMPV/C) poses a significant threat to poultry health.
  • Effective control strategies for aMPV/C infections in commercial turkeys are crucial.

Purpose of the Study:

  • To investigate the effects of in ovo inoculation of aMPV/C on turkey embryos and subsequent immune responses.
  • To evaluate the protective efficacy of in ovo immunization against aMPV/C challenge.

Main Methods:

  • Commercial turkey eggs were inoculated with aMPV/C at embryonation day 24.
  • Virus replication was quantified using RT-PCR.
  • Histological lesions and immune cell responses (mitogenic response, cytokine gene expression) were assessed.
  • Humoral immunity (IgG) and protection against challenge were evaluated.

Main Results:

  • In ovo inoculation did not impact egg hatchability.
  • aMPV/C replicated in respiratory tissues (turbinate, trachea, lung) post-hatch.
  • Mild lymphoid infiltration was observed in the turbinate mucosa.
  • aMPV/C exposure modulated splenocyte and thymocyte responses and upregulated IFN-γ and IL-10 in turbinate tissue.
  • aMPV/C-specific IgG was detected in serum and lachrymal fluid.
  • In ovo immunized turkeys showed protection against a pathogenic aMPV/C challenge at 3 weeks of age.

Conclusions:

  • In ovo inoculation of aMPV/C is safe regarding hatchability and induces a protective immune response in turkeys.
  • This approach offers a promising strategy for early-stage protection against aMPV/C in commercial poultry.
  • Further research into optimizing in ovo immunization protocols is warranted.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...